IL-6 plays an important role in various inflammatory ocular diseases, including
diabetic retinopathy. Müller cells are the major source of inflammatory mediators, including
IL-6, in the retina. However, the mechanism of regulating
IL-6 production in these cells remains unclear. Examination of signaling pathways in human
retinal Müller cells (MIO-M1 cell line) cultured with IL-1β, TNF-α,
IL-6,
IL-8,
VEGF, IFN-γ,
glucose or
mannitol showed that IL-1β was the most potent stimulator of
IL-6 production. In addition,
IL-1 β also increased NF-κB p50
protein level and phosphorylation of
p38 MAPK, ERK1/2 and c-Jun. Induction of
IL-6 production by IL-1β was significantly reduced by addition of
p38 MAPK (
SB203580), MEK1/2 (
U0126) or NF-κB (BAY11-7082) inhibitors, with the highest effect being observed with
SB203580. To explore the specific elements in
IL-6 promoter responsible for IL-1β-induction of
IL-6 expression, a series of plasmids bearing various
IL-6 promoter mutations were transiently expressed in MIO-MI cells cultured in the presence or absence of IL-1β (10ng/ml) and/or
SB203580 (10µM). Results showed that
IL-6 promoter activity of the parent pIL-6-Luc651 was significantly enhanced by IL-1β, but the level was significantly attenuated by
SB203580. Furthermore, the
IL-6 promoter activity was also reduced upon deletion of NF-κB,
AP-1 or C/EBP binding sites, with NF-κB deletion being the greatest. These results are the first demonstration that IL-1β induces
IL-6 production in Müller cells by activation of
IL-6 promoter activity predominantly through the
p38 MAPK/NF-κB pathway.